BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 1300882)

  • 1. Plasma manipulation in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Remuzzi G; Ruggenenti P
    Ann Med Interne (Paris); 1992; 143 Suppl 1():19-26. PubMed ID: 1300882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
    Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura and related disorders.
    Ruggenenti P; Remuzzi G
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):219-41. PubMed ID: 2107174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
    Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
    Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
    Tuncer HH; Oster RA; Huang ST; Marques MB
    Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy.
    Egan JA; Hay SN; Brecher ME
    J Clin Apher; 2004; 19(4):165-7. PubMed ID: 15597353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial, recurring plasma infusion dependent thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
    Litwin M; Smirska E
    Pol Merkur Lekarski; 2000 Apr; 8(46):289-90. PubMed ID: 10897656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombotic microangiopathy in adults].
    Barrientos GJ; Michelangelo H
    Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
    Michael M; Elliott EJ; Craig JC; Ridley G; Hodson EM
    Am J Kidney Dis; 2009 Feb; 53(2):259-72. PubMed ID: 18950913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.
    Wyllie BF; Garg AX; Macnab J; Rock GA; Clark WF;
    Br J Haematol; 2006 Jan; 132(2):204-9. PubMed ID: 16398654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.